ESC 365 - Novel potassium binders help optimize RAASi therapy in heart failure patients: a systematic review and meta-analysis of RCT

HFA Premium Access

Novel potassium binders help optimize RAASi therapy in heart failure patients: a systematic review and meta-analysis of RCT

Session: Pharmacotherapy

Topic: Cardiovascular Pharmacotherapy

Speaker: Doctor C. Basile (Naples, IT)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Doctor Christian Basile

University of Naples Federico II, Naples (Italy)

1 presentation

1 follower

6 more presentations in this session

Real-world use of sodium-glucose co-transporter 2 inhibitors in patients with heart failure and reduced ejection fraction: data from the Swedish heart failure registry

Speaker: Doctor D. Stolfo (Trieste, IT)

Dapagliflozin reduces loop diuretic requirement over time in patients with heart failure with mildly reduced or preserved ejection fraction in the DELIVER Trial

Speaker: Doctor S. Chatur (Boston, US)

Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction results from the EMPULSE trial.

Speaker: Doctor J. Tromp (Singapore, SG)

Safety of continuing mineralocorticoid receptor antagonists treatment in patients with heart failure with reduced ejection fraction and severe kidney disease: data from swedish heart failure registry

Speaker: Doctor F. Guidetti (Stockholm, SE)

Mineralocorticoid receptor antagonist initiation during admission is associated with improved outcomes irrespective of ejection fraction in patients with acute heart failure

Speaker: Ms I. Beldhuis (Groningen, NL)

Access the full session

Pharmacotherapy

Speakers: Doctor C. Basile, Doctor D. Stolfo, Doctor S. Chatur, Doctor J. Tromp, Doctor F. Guidetti...

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources